Director – CART Class Expansion
| Company | Bristol Myers Squibb |
|---|---|
| Location | Summit, NJ, USA, Princeton, NJ, USA |
| Salary | $Not Provided – $Not Provided |
| Type | Full-Time |
| Degrees | Master’s, PharmD, PhD |
| Experience Level | Senior, Expert or higher |
Requirements
- Advanced Medical/Biology degree (MS, PhD, PharmD) with clinical and/or minimal 5 years of Pharma industry experience required
- Deep knowledge of US Healthcare system and Cell Therapy customer needs
- Highly organized, efficient, and motivated individual with the ability to lead multiple projects and initiatives across matrix teams
- Strong interpersonal and communication skills to navigate complex situations and gain alignment with diverse stakeholders
- Excellent verbal & written communication skills, with the presence to interface with management teams
- Proven agility in prioritizing and navigating competing demands
- Estimated 15-20% travel (as applicable)
Responsibilities
- Develop and execute medical strategic and tactical plan that supports the expansion of the CAR T class
- Identify gaps and create innovative solutions to improve delivery of transformational Cell Therapy to patients
- Represent US Medical affairs on key Cell Therapy workstreams to deliver on organizational goals and reinforce the impact of Medical Affairs
- Collaborate closely with cross-functional partners (Field Medical, WW Medical, Commercial, Clinical, Legal, Regulatory, etc.) to leverage synergy, enhance communication, and ensure alignment
- Advance evidence generation aligned to CAR T class expansion in partnership with other Medical and HEOR colleagues
- Provide oversight to medical activities around the Breyanzi LCM indications (CLL, MCL, FL, and MZL)
Preferred Qualifications
-
No preferred qualifications provided.